BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7461700)

  • 1. [Epidemiological studies of increasing appearances of Proteus inconstans (Providencia stuartii) infections (author's transl)].
    Kopf PO; Freitag V; Caselitz FH; Kolbe S
    Immun Infekt; 1980; 8(3):96-100. PubMed ID: 7461700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nosocomial infections with Providencia stuartii (Proteus inconstans) (author's transl)].
    Kopf PO; Freitag V
    Dtsch Med Wochenschr; 1979 Aug; 104(32):1129-32. PubMed ID: 467264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance in Providencia stuartii isolated in hospitals.
    McHale PJ; Keane CT; Dougan G
    J Clin Microbiol; 1981 Jun; 13(6):1099-104. PubMed ID: 7251830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriocine typing of Providencia isolates.
    Al-Jumaili IJ; Fenwick GA
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):202-7. PubMed ID: 654675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nosocomial infections of the urinary tract by Proteus rettgeri (author's transl)].
    Bauernfeind A; Wiersma G
    Immun Infekt; 1977 Aug; 5(4):138-41. PubMed ID: 914313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Providencia stuartii infections.
    Keane CT; English LF; Wise R
    Lancet; 1975 Nov; 2(7943):1045. PubMed ID: 53535
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
    Hollick GE; Nolte FS; Calnan BJ; Penner JL; Barton LJ; Spellacy A
    Eur J Clin Microbiol; 1984 Dec; 3(6):521-5. PubMed ID: 6526019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine resistance and the lipids of Providencia stuartii.
    Thomas B; Stickler DJ
    Microbios; 1979; 24(97-98):141-50. PubMed ID: 530092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological aspects of Proteus infections with particular reference to phage typing.
    France DR; Markham NP
    J Clin Pathol; 1968 Jan; 21(1):97-102. PubMed ID: 5697342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased growth of chemotherapy-resistant hospital organisms through disinfection (author's transl)].
    Bauerfeind A
    MMW Munch Med Wochenschr; 1976 Jul; 118(27):871-4. PubMed ID: 820967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
    Adler JL; Burke JP; Martin DF; Finland M
    Ann Intern Med; 1971 Oct; 75(4):517-30. PubMed ID: 5209286
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.
    Prentice B; Robinson BL
    Can Med Assoc J; 1979 Sep; 121(6):745-9. PubMed ID: 519613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providencia stuartii infections: a review of 117 cases over an eight year period.
    McHale PJ; Walker F; Scully B; English L; Keane CT
    J Hosp Infect; 1981 Jun; 2(2):155-65. PubMed ID: 6174578
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug resistance of Proteus vulgaris, Proteus morganii and Providencia rettgeri isolated from diagnostic specimens].
    Gołuszko P; Gospodarek E; Bugalski R
    Przegl Epidemiol; 1987; 41(3):319-23. PubMed ID: 3324173
    [No Abstract]   [Full Text] [Related]  

  • 18. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.
    O'Hara CM; Brenner FW; Miller JM
    Clin Microbiol Rev; 2000 Oct; 13(4):534-46. PubMed ID: 11023955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R plasmids in gentamicin-tobramycin-carbenicillin-resistant nosocomial strains of Proteus rettgeri and Proteus morgani.
    Výmola M; Zahradnický J; Krcméry V; Trojanová M; Chaloupecký V
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(3):382-14. PubMed ID: 570994
    [No Abstract]   [Full Text] [Related]  

  • 20. Nosocomial urinary tract infections caused by two O-serotypes of Providencia stuartii in one hospital.
    Whiteley GR; Penner JL; Stewart IO; Stokan PC; Hinton NA
    J Clin Microbiol; 1977 Dec; 6(6):551-4. PubMed ID: 591628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.